Skip to main content

Month: January 2024

Southern States Bancshares, Inc. Announces Fourth Quarter 2023 Financial Results

Fourth Quarter 2023 Performance and Operational HighlightsCore net income(1) of $7.3 million, or $0.81 per diluted share(1) Net income of $8.9 million, or $0.99 per diluted share Net interest income of $20.4 million, a decrease of $327,000 from the prior quarter Net interest margin (“NIM”) of 3.69%, down 9 basis points from the prior quarter NIM of 3.71% on a fully-taxable equivalent basis (“NIM – FTE”)(1) Return on average assets (“ROAA”) of 1.53%; return on average stockholders’ equity (“ROAE”) of 17.02%; and return on average tangible common equity (“ROATCE”)(1) of 18.62% Core ROAA(1) of 1.26%; and core ROATCE(1) of 15.26% Efficiency ratio of 41.48%; and core efficiency ratio of 45.78% Linked-quarter loan growth was 24.7% annualized Linked-quarter total deposits grew 21.1% annualized Linked-quarter total deposits, excluding...

Continue reading

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer (CEO), effective January 27, 2024, and will also be appointed to the Company’s Board of Directors. SIGA’s current CEO, Dr. Phil Gomez, will retire from SIGA on January 26, 2024. “The appointment of Diem Nguyen as our new CEO marks a significant milestone for SIGA as we continue to expand our partnerships with governments across the world in global health security initiatives and medical countermeasure preparedness,” said Joseph (Chip) Marshall, chair of the Nominating and Corporate Governance Committee of the Company’s Board of Directors. “Diem’s scientific expertise and...

Continue reading

Platinex Reports the Voting Results from its AGSM and Announces New Director

TORONTO, Jan. 22, 2024 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) reports the voting results from its Annual General Special Meeting of shareholders (the “Meeting”) held on January 16, 2024. Shareholders holding 129,324,513 shares or 42.53% of the issued and outstanding shares of the Company (as at the record date January 16, 2024) were represented in person or by proxy at the Meeting and voted in favour of all matters brought before the Meeting as outlined in the Company’s Management Information Circular dated December 08, 2023. The results have been filed on SEDAR, www.sedar.com. The Company’s shareholders set the number of directors of the Company for the ensuing year at six. The six Directors included one new nominee appointee, Mr. Rajesh Sharma. Platinex...

Continue reading

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

HOUSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumors, announced today that the United States Adopted Names (USAN) Council, and the World Health Organization (WHO) International Nonproprietary Names (INN) expert committee has approved “neldaleucel” as the nonproprietary (generic) name for MT-601, a multi-tumor associated antigen (multiTAA)-specific T cell product candidate for the treatment of patients with lymphoma. The USAN Council in close collaboration with the WHO established INN expert committee select and assign a single unique name of worldwide acceptability for each active substance that is to be marketed as a pharmaceutical,...

Continue reading

Surge Copper Intersects 548 metres grading 0.36% CuEq including 30 metres grading 0.61% CuEq at the Berg Deposit

Vancouver, British Columbia, Jan. 22, 2024 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce assay results from drill hole BRG23-244, the second hole of the Company’s 2023 drilling program testing the deeper portions of the large Berg copper-molybdenum deposit in West-central British Columbia. HighlightsHole BRG23-244 intersected 548 metres grading 0.36% CuEq2 (0.28% copper, 0.018% molybdenum, 3.6 g/t silver, and 0.02 g/t gold) from 12 metres depth (copper equivalent “CuEq” is reported net of by-product recoveries, please see Table 1, footnote 2 for details) The upper portion of the hole encountered the chalcocite blanket returning a subinterval with elevated copper of 108 metres grading 0.46% CuEq (0.42% copper, 0.007% molybdenum, 2.6 g/t silver,...

Continue reading

Fireweed Intersects 44 m true width of 18.98% Zinc, 2.24% Lead and 114.9 g/t Silver, and 47 m true width of 11.58% Zinc, 1.75% Lead and 54.9 g/t Silver at Boundary Zone

Map 1Map 1: Macpass Project and Mactung Project locationsMap 2Map 2: Location of 2023 Boundary Zone drillholes, cross sections and long section M–M’. See below for sections.Map 3Map 3: Mineralized intervals in 2023 drilling and pre-2023 drilling defining a stratiform laminated to massive sulphide zone that is connected at depth (purple polygon) and a broader envelope of vein, breccia, and other stratiform zinc mineralization, showing significant areal extent (within green dashed line).Long Section M–M’Long Section M–M’ – Estimated true thickness interpretation and selected intersections with zinc grades shown within the laminated to massive sulphide stratiform zone of pyrite-sphalerite-galena mineralization at Boundary Zone. Halo vein and breccia mineralization is not included in this long section.Cross...

Continue reading

Amarin Chairman & CEO Issue Letter to Shareholders

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Chairman of the Board, Odysseas Kostas, M.D., and President & CEO, Patrick Holt, issued the following letter to Amarin shareholders: Dear Fellow Amarin Shareholders, 2023 was an important year for Amarin, marked by necessary transition and change. With a new board focused on shareholders, we undertook significant actions to strengthen the Company. We restructured the management team, redesigned our operations and approach in Europe, improved our financial discipline, streamlined the U.S. business to maximize cash flows and progressed our Rest of World (RoW) rollout. We believe the company is fundamentally in a much stronger position today. As shareholders ourselves, we remain disappointed...

Continue reading

Macerich Announces Tax Treatment Of 2023 Dividends

SANTA MONICA, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) today announced the tax treatment for dividend distributions taxable in 2023 on its Common Stock. During the calendar year ended December 31, 2023 Macerich paid dividends of $.68 per share. The 2023 dividends are classified for income tax purposes as follows for The Macerich Company, Common Stock, CUSIP # 554382101:Record Date Payable Date Rate per Share 2023 Taxable Ordinary Dividends 2023 Section 199A Dividends* 2023 Total Capital Gain Distribution2/17/2023 3/3/2023 $0.17 $0.09 $ 0.09 $0.085/19/2023 6/2/2023 $0.17 $0.09 $ 0.09 $0.088/18/2023 9/8/2023 $0.17 $0.09 $ 0.09 $0.0811/9/2023 12/1/2023 $0.17 $0.09 $ 0.09 $0.08* These amounts are included in the 2023 Taxable Ordinary Dividends column. About Macerich Macerich is a fully...

Continue reading

Koryx Copper Files an Amended PEA for Its Haib Copper Project

VANCOUVER, British Columbia, Jan. 22, 2024 (GLOBE NEWSWIRE) — Koryx Copper Inc. (formerly Deep-South Resources) (“Koryx” or “the Company“) (TSX-V: KRY) announces that, further to its news release dated February 7, 2023 confirming a continuous disclosure audit of the Company by the British Columbia Securities Commission (the “BCSC”), it has filed an amended preliminary economic assessment (“PEA”) technical report (the “Amended Report”) for the Haib Copper project near Noordover in the south of Namibia. The amendment has not impacted the material components of the PEA, notably resources, metallurgy, mine plan, cost estimates, economic analysis and environmental matters (see the Company’s news release dated December 15, 2020 announcing the results of its PEA). As disclosed in its...

Continue reading

Medical Tubing Market to Surpass 18.66 Billion by 2030 Drives Due to the Technological Advancements

SkyQuest projects that the medical tubing market will attain a USD 18.66 billion value by 2030, with a CAGR of 6.2% over the forecast period (2023-2030). The medical tubing market is being driven by continuous technological advancements. Innovations like antimicrobial coatings and biocompatible materials are enhancing patient safety and infection control, boosting demand for medical tubing in healthcare settings. Westford,USA, Jan. 22, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, increasing global healthcare expenditure is a significant driver for the medical tubing market. Growing investments in healthcare infrastructure, both in developed and emerging markets, are fueling the demand for medical tubing products used in various medical procedures. Browse in-depth TOC on the “Medical Tubing Market”Pages –...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.